These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24217578)

  • 1. Soluble forms of polyQ-expanded huntingtin rather than large aggregates cause endoplasmic reticulum stress.
    Leitman J; Ulrich Hartl F; Lederkremer GZ
    Nat Commun; 2013; 4():2753. PubMed ID: 24217578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of endoplasmic reticulum stress counteracts neuronal cell death and protein aggregation caused by N-terminal mutant huntingtin proteins.
    Reijonen S; Putkonen N; Nørremølle A; Lindholm D; Korhonen L
    Exp Cell Res; 2008 Mar; 314(5):950-60. PubMed ID: 18255062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IRE1 plays an essential role in ER stress-mediated aggregation of mutant huntingtin via the inhibition of autophagy flux.
    Lee H; Noh JY; Oh Y; Kim Y; Chang JW; Chung CW; Lee ST; Kim M; Ryu H; Jung YK
    Hum Mol Genet; 2012 Jan; 21(1):101-14. PubMed ID: 21954231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of neuronal inclusions of patients with Huntington's disease reveals a broad range of N-terminal fragments of expanded huntingtin and insoluble polymers.
    Hoffner G; Island ML; Djian P
    J Neurochem; 2005 Oct; 95(1):125-36. PubMed ID: 16181417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting expression of expanded polyglutamine proteins to the endoplasmic reticulum or mitochondria prevents their aggregation.
    Rousseau E; Dehay B; Ben-Haïem L; Trottier Y; Morange M; Bertolotti A
    Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9648-53. PubMed ID: 15210964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble Oligomers of PolyQ-Expanded Huntingtin Target a Multiplicity of Key Cellular Factors.
    Kim YE; Hosp F; Frottin F; Ge H; Mann M; Hayer-Hartl M; Hartl FU
    Mol Cell; 2016 Sep; 63(6):951-64. PubMed ID: 27570076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sigma-1 receptor is involved in degradation of intranuclear inclusions in a cellular model of Huntington's disease.
    Miki Y; Tanji K; Mori F; Wakabayashi K
    Neurobiol Dis; 2015 Feb; 74():25-31. PubMed ID: 25449906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pridopidine reduces mutant huntingtin-induced endoplasmic reticulum stress by modulation of the Sigma-1 receptor.
    Shenkman M; Geva M; Gershoni-Emek N; Hayden MR; Lederkremer GZ
    J Neurochem; 2021 Jul; 158(2):467-481. PubMed ID: 33871049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Converging pathways in the occurrence of endoplasmic reticulum (ER) stress in Huntington's disease.
    Vidal R; Caballero B; Couve A; Hetz C
    Curr Mol Med; 2011 Feb; 11(1):1-12. PubMed ID: 21189122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity.
    Atwal RS; Xia J; Pinchev D; Taylor J; Epand RM; Truant R
    Hum Mol Genet; 2007 Nov; 16(21):2600-15. PubMed ID: 17704510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ER stress-induced eIF2-alpha phosphorylation underlies sensitivity of striatal neurons to pathogenic huntingtin.
    Leitman J; Barak B; Benyair R; Shenkman M; Ashery U; Hartl FU; Lederkremer GZ
    PLoS One; 2014; 9(3):e90803. PubMed ID: 24594939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease.
    Lee WC; Yoshihara M; Littleton JT
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3224-9. PubMed ID: 14978262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic.
    Takahashi T; Kikuchi S; Katada S; Nagai Y; Nishizawa M; Onodera O
    Hum Mol Genet; 2008 Feb; 17(3):345-56. PubMed ID: 17947294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p97 Homologs from Caenorhabditis elegans, CDC-48.1 and CDC-48.2, suppress the aggregate formation of huntingtin exon1 containing expanded polyQ repeat.
    Nishikori S; Yamanaka K; Sakurai T; Esaki M; Ogura T
    Genes Cells; 2008 Aug; 13(8):827-38. PubMed ID: 18782221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant huntingtin forms in vivo complexes with distinct context-dependent conformations of the polyglutamine segment.
    Persichetti F; Trettel F; Huang CC; Fraefel C; Timmers HT; Gusella JF; MacDonald ME
    Neurobiol Dis; 1999 Oct; 6(5):364-75. PubMed ID: 10527804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-PolyQ Antibodies Recognize a Short PolyQ Stretch in Both Normal and Mutant Huntingtin Exon 1.
    Owens GE; New DM; West AP; Bjorkman PJ
    J Mol Biol; 2015 Jul; 427(15):2507-2519. PubMed ID: 26047735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small molecule inducers of heat-shock response reduce polyQ-mediated huntingtin aggregation. A possible therapeutic strategy.
    Herbst M; Wanker EE
    Neurodegener Dis; 2007; 4(2-3):254-60. PubMed ID: 17596719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emerging role of the first 17 amino acids of huntingtin in Huntington's disease.
    Arndt JR; Chaibva M; Legleiter J
    Biomol Concepts; 2015 Mar; 6(1):33-46. PubMed ID: 25741791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired ERAD and ER stress are early and specific events in polyglutamine toxicity.
    Duennwald ML; Lindquist S
    Genes Dev; 2008 Dec; 22(23):3308-19. PubMed ID: 19015277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a recruitment and sequestration mechanism in Huntington's disease.
    Preisinger E; Jordan BM; Kazantsev A; Housman D
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1029-34. PubMed ID: 10434302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.